Active Not Recruiting OBSERVATIONAL NCT06798805
Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Updated 1 time since 2025 Last updated: Jan 28, 2025 Started: Feb 15, 2022 Primary completion: Aug 8, 2024 Completion: Aug 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Essential Thrombocythemia (ET) and Myelofibrosis (MF), this trial is ongoing. The trial is conducted by IRCCS Azienda Ospedaliero-Universitaria di Bologna and has accumulated 1 data snapshot since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Data source: IRCCS Azienda Ospedaliero-Universitaria di Bologna
For direct contact, visit the study record on ClinicalTrials.gov .